Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Temasek €1.5 billion guaranteed notes offering
The guaranteed notes are due 2027 and 2033
Aon $750 million senior notes offering
The investment-grade notes are due 2033
Assurant $175 million senior notes offering
We advised Assurant on the senior notes offering
Leidos $750 million notes offering and tender offer
We advised Leidos in connection with the transactions
Mizuho Financial Group $2.6 billion senior notes offering
The senior callable fixed-to-fixed reset rate notes are due 2029, 2031 and 2034
Eli Lilly $4 billion notes offering
The investment-grade notes are due 2026, 2033, 2053 and 2063
Chindata Group Holdings $300 million notes offering
The high-yield notes are due 2026
PPL Capital Funding $1 billion exchangeable senior notes offering
We advised PPL on the transaction
Mirion Technologies $150 million registered direct offering
We advised Mirion on the offering
Bombardier cash tender offer
The company purchased certain debt securities